Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2796832 | Diabetes Research and Clinical Practice | 2013 | 5 Pages |
Abstract
Patients with T2DM show an imbalance of bone mineral metabolism, and co-existence of nephropathy tends to aggravate this. Serum osteocalcin and 24-h hydroxyproline may be considered useful biochemical markers for monitoring possible bone mineral metabolism disorder in T2DM patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Hui Chen, Xiaoxu Li, Ruihong Yue, Xuan Ren, Xiude Zhang, Anming Ni,